<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for NBIX</title>
    <link />
    <description>Headlines for Neurocrine Biosciences, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Neurocrine Biosciences' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transc</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1442151-neurocrine-biosciences-ceo-presents-at-bank-of-america-merrill-lynch-health-care-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 16 May 2013 20:00:58 GMT</pubDate>
    </item>
    <item>
      <title>A Look At Neurocrine's VMAT-2 Inhibitor As Phase IIb Data Nears</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1419511-a-look-at-neurocrine-s-vmat-2-inhibitor-as-phase-iib-data-nears.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 10 May 2013 13:37:44 GMT</pubDate>
    </item>
    <item>
      <title>Neurocrine Biosciences Inc. Stock Downgraded (NBIX)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11915421/1/neurocrine-biosciences-inc-stock-downgraded-nbix.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 07 May 2013 05:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Neurocrine Biosciences CEO Discuses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1402391-neurocrine-biosciences-ceo-discuses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 03 May 2013 23:31:02 GMT</pubDate>
    </item>
    <item>
      <title>2 Pharmaceutical Buys Under $15 With Strong Catalysts</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1351621-2-pharmaceutical-buys-under-15-with-strong-catalysts.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 18 Apr 2013 13:32:00 GMT</pubDate>
    </item>
    <item>
      <title>VIX - Options Volatility And Market Sonar: Monday Recap</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1328281-vix-options-volatility-and-market-sonar-monday-recap.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 08 Apr 2013 17:35:36 GMT</pubDate>
    </item>
    <item>
      <title>3 Stocks Near 52-Week Highs Worth Selling</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/04/3-stocks-near-52-week-highs-worth-selling-25/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 04 Apr 2013 12:51:20 GMT</pubDate>
    </item>
    <item>
      <title>Neurocrine Biosciences Commences Phase IIB Study of Elagolix in Uterine Fibroids</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3450221/neurocrine-biosciences-commences-phase-iib-study-of-elagolix-in-uterine-fibroids.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 27 Mar 2013 07:20:25 GMT</pubDate>
    </item>
    <item>
      <title>A Quick Look At 8 Biotechs Ready To Gain Momentum</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1263951-a-quick-look-at-8-biotechs-ready-to-gain-momentum.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 11 Mar 2013 15:44:16 GMT</pubDate>
    </item>
    <item>
      <title>Neurocrine Biosciences Inc. Stock Upgraded (NBIX)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11838738/1/neurocrine-biosciences-inc-stock-upgraded-nbix.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 12 Feb 2013 04:04:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Jefferies Reiterates Buy Rating, Raises PT on Neurocrine Biosciences After Earnings Report</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/02/3322516/update-jefferies-reiterates-buy-rating-raises-pt-on-neur.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 11 Feb 2013 11:40:00 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Highs</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3322291/stocks-hitting-52-week-highs.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 11 Feb 2013 10:30:45 GMT</pubDate>
    </item>
    <item>
      <title>3 Humongous Health-Care Stocks This Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/09/3-humongous-health-care-stocks-this-week-16/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 09 Feb 2013 11:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Neurocrine Biosciences' CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1168511-neurocrine-biosciences-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 08 Feb 2013 14:08:04 GMT</pubDate>
    </item>
    <item>
      <title>Earnings Scheduled For February 8, 2013</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/02/3316228/earnings-scheduled-for-february-8-2013.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 08 Feb 2013 02:31:32 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Afternoon Market Update: Markets Edge Toward Record Highs, Arch Coal Falls Further</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/02/3306548/mid-afternoon-market-update-markets-edge-toward-record-highs-arch-coal-f.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 05 Feb 2013 15:57:29 GMT</pubDate>
    </item>
    <item>
      <title>Neurocrine Biosciences: Elagolix-Channel Checks And Expert Opinion Reveal Small Market Size, Unfavor</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1098021-neurocrine-biosciences-elagolix-channel-checks-and-expert-opinion-reveal-small-market-size-unfavorable-incentives.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 07 Jan 2013 10:04:48 GMT</pubDate>
    </item>
    <item>
      <title>Neurocrine Biosciences Presents at Deutsche Bank's 2012 dbAccess BioFEST (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1044901-neurocrine-biosciences-presents-at-deutsche-bank-s-2012-dbaccess-biofest-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 04 Dec 2012 16:44:01 GMT</pubDate>
    </item>
    <item>
      <title>Neurocrine Biosciences' CEO Presents at Lazard Capital Market's 9th Annual Healthcare Conference (Tr</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1004011-neurocrine-biosciences-ceo-presents-at-lazard-capital-market-s-9th-annual-healthcare-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 13 Nov 2012 15:16:01 GMT</pubDate>
    </item>
    <item>
      <title>The Most Promising Dividends in Pharmaceutical Companies</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/07/the-most-promising-dividends-in-pharmaceutical-com/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 07 Nov 2012 20:40:00 GMT</pubDate>
    </item>
  </channel>
</rss>
